- Home
- CPD Activities
- Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
| Name | INFECTIOUS DISEASES INSTITUTE |
|---|
| Activity Title | Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial |
|---|
| Details | Journal club |
|---|
| Competence | General Medicine |
|---|
| Start Date | 22-07-2024 |
|---|
| End Date | 22-07-2024 |
|---|
| Event Time | 09:00 AM |
|---|
| Location | zoom |
|---|
| Cost (UGX) | 0 |
|---|
| CPD Points | 1 |
|---|